XIFIN, Inc. + Fabric Genomics
Fabric Genomics and XIFIN partner to expand access to clinical genomics
Expanding access to genomic testing
Fabric Enterprise and XIFIN LIS together provide a seamless informatics solution for NGS testing. Now, clinical labs can quickly adopt advanced molecular genomic testing with a complete, best-in-class and integrated workflow solution from test requisition to data analysis to clinical report, allowing healthcare providers to advance precision medicine programs and improve patient outcomes.
Implement informatics for NGS with confidence
 Seamless Access
 Seamless AccessLabs can seamlessly access and interpret genomic data to quickly generate clinical case reports
 Scalability
 ScalabilityFacilitate high complexity labs to accelerate adoption and scaling of genomic testing in a clinical settingÂ
 Collaborative Environment
 Collaborative EnvironmentXIFIN LIS supports multi-specialty workflows, including NGS, and facilitates multidisciplinary care team collaboration.
 Improve patient outcomes
![Support icon](https://fabricgenomics.com/wp-content/uploads/2019/11/Icon-support.svg"){kind=icon}
 Improve patient outcomesIntegrated workflow solution from test requisition to data analysis to clinical report, allowing healthcare providers to advance precision medicine programs and improve patient outcomes.
Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a distribution agreement with XIFIN, the leader in revenue cycle management and laboratory information systems, that will increase mainstream access to cutting-edge genomic technologies and testing.
Featured Webinars
Achieving Success with Next-Generation Sequencing: AI-Driven Scale and a Strong Reimbursement Strategy
Labs from every sector – private, reference, hospital, and academic – may be considering expansion of their test offering to include next generation sequencing (NGS). However, before implementing NGS, there are a number of factors that lab leaders must carefully consider to ensure the successful implementation and sustainability of their NGS program.
Hear XIFIN and Fabric Genomics experts discuss practical factors such as processes, people, and technology, as well as more advanced topics such as reimbursement insights and IT strategies.
Pathway to Success with Next Generation Sequencing: Reimbursement Insight and IT Strategies
Labs from every sector – private, reference, hospital, and academic – may be considering expansion of their test offering to include next generation sequencing (NGS). However, before implementing NGS, there are a number of factors that lab leaders must carefully consider to ensure the successful implementation and sustainability of their NGS program.
Hear XIFIN and Fabric Genomics experts discuss practical factors such as processes, people, and technology, as well as more advanced topics such as reimbursement insights and IT strategies.
